CIK 0001999480
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 834210124
- Phone
- +1 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,567,247
- in 1 filing
Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | York Gwill Director | Grant or award · Stock Option (right to buy) | +10,958 | 10,958 | ||
| 2026-01-02 | York Gwill Director | Grant or award · Stock Option (right to buy) | +5,243 | $11.82 | $62K | 5,243 |
| 2025-05-13 | York Gwill Director | Grant or award · Stock Option (right to buy) | +15,287 | 15,287 | ||
| 2025-01-02 | York Gwill Director | Grant or award · Stock Option (right to buy) | +19,558 | $3.17 | $62K | 19,558 |
| 2024-02-06 | York Gwill Director | Conversion | +23,917 | 23,917 | ||
| 2024-02-06 | York Gwill Director | Conversion · Series A Preferred Stock | −53,196 | 0 | ||
| 2024-02-01 | York Gwill Director | Grant or award · Stock Option (right to buy) | +30,574 | 30,574 | ||
| 2024-02-01 | York Gwill Director | Grant or award · Stock Option (right to buy) | +3,083 | $11.88 | $37K | 3,083 |
Page 1 of 1 · 8 trades